Compare Edwards Lifesciences Corporation Common Stock (EW) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Immunovant Inc. Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 7.5× Immunovant Inc. Common Stock's market cap, and Edwards Lifesciences Corporation Common Stock is more actively traded (3,508,027 versus 1,131,364). Which is the better fit depends on your goals.
| EW | IMVT | |
|---|---|---|
Market Cap | $49.44B | $6.62B |
Volume | 3,508,027 | 1,131,364 |
Sector | Health | Health |
52-Week High | $95.18 | $44.96 |
52-Week Low | $72.65 | $17.03 |
Enterprise Value | $45.90B | $5.72B |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
